Caption Management, LLC Cytokinetics Inc Transaction History
Caption Management, LLC
- $8.03 Billion
- Q2 2025
A detailed history of Caption Management, LLC transactions in Cytokinetics Inc stock. As of the latest transaction made, Caption Management, LLC holds 72,700 shares of CYTK stock, worth $4.09 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
72,700
Previous 10,500
592.38%
Holding current value
$4.09 Million
Previous $421,000
470.55%
% of portfolio
0.03%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding CYTK
# of Institutions
370Shares Held
129MCall Options Held
3.62MPut Options Held
1.14M-
T. Rowe Price Investment Management, Inc. Baltimore, MD17.6MShares$991 Million0.37% of portfolio
-
Black Rock Inc. New York, NY14.7MShares$826 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA12MShares$675 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA7.83MShares$441 Million0.05% of portfolio
-
State Street Corp Boston, MA6.37MShares$359 Million0.01% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $5.3B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...